551 related articles for article (PubMed ID: 25262223)
1. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
3. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
5. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
6. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
[TBL] [Abstract][Full Text] [Related]
7. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
Kim WW; Park HY; Jung JH
Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
[TBL] [Abstract][Full Text] [Related]
8. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
9. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
10. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
[TBL] [Abstract][Full Text] [Related]
11. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
[TBL] [Abstract][Full Text] [Related]
12. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
[TBL] [Abstract][Full Text] [Related]
13. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
14. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
[TBL] [Abstract][Full Text] [Related]
15. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
[TBL] [Abstract][Full Text] [Related]
16. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
Krook KA; Fedewa SA; Chen AY
Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
[TBL] [Abstract][Full Text] [Related]
17. Treatment Outcomes and Risk Factors for Recurrence After Definitive Surgery of Locally Invasive Well-Differentiated Papillary Thyroid Carcinoma.
Kim JW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Thyroid; 2016 Feb; 26(2):262-70. PubMed ID: 26566765
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features.
Xu S; Huang H; Wang X; Liu S; Xu Z; Liu J
Br J Surg; 2021 Apr; 108(4):395-402. PubMed ID: 33793787
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.
Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2011 Apr; 35(4):767-72. PubMed ID: 21181469
[TBL] [Abstract][Full Text] [Related]
20. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]